NEW YORK, Sept 28 - ValiGen has signed a five-year deal to subscribe to all of Celera Genomic’s (NYSE: CRA) database products, the companies said Thursday.

Valigen, of Newton, PA, said it would access the databases through Celera’s web-based Discovery System.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.